Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.265 USD | +2.67% | +4.19% | -16.75% |
Apr. 18 | Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board | CI |
Mar. 12 | Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.75% | 101M | |
+0.93% | 43.84B | |
+5.97% | 41.68B | |
+45.15% | 41.25B | |
-10.92% | 27.04B | |
+8.02% | 25.53B | |
-25.24% | 18.18B | |
-3.47% | 12.29B | |
+24.72% | 12.29B | |
+6.86% | 11.15B |
- Stock Market
- Equities
- ANIX Stock
- News Anixa Biosciences, Inc.
- Anixa Biosciences Starts Dosing Patients in Preventative Breast Cancer Vaccine Study; Shares Rise